Total Funding
49
61
Total FundingSeed raised
Growth Score 49 in past quarter
-22 pts
Heat Score 61 in past quarter
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
37006
Relavo offers a device to prevent infection in peritoneal dialysis, a form of at-home treatment for end-stage renal disease.
- Sarah Lee: CEO & Co-Founder
- Anna Bailey: Co-founder and Chief Innovation Officer
About the Company
Relavo is a medical device company that is revolutionizing the way kidney failure patients are treated. Relavo's PeritoneX technology aims to make home dialysis more accessible by lowering the risk of infection. The PeritoneX® is an in-line connection device designed to disinfect dialysis tubes at all PD system connection points.
Women Founded